Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2006.0050


Positive Perioperative (ECF) Chemotherapy Trial for Gastric Cancer: Primary chemotherapy or surgery?
Evangelos Briasoulis, MD, Theodore Liakakos, MD, Nikolaos Xeropotamos, Dimosthenis Ziogas, MD, Dimitrios Roukos,* MD, and Michael Fatouros, MD

The MAGIC trial provides, for a first time in the literature, level I evidence for a survival benefit of a new treatment option. However, the trial was designed to provide overall data for all patients with stage II, IIIA and IIIB and not not stage-specific subgroups survival analysis. Although the study provides robust results, can perioperative chemotherapy replace current standard surgery in the clinical treatment practice of operable gastric cancer?


Find Delta Dental, MetLife Dental, Aetna Dentist, New York Dentist, San Francisco Dentist, Boston Dentist, Chicago Dentist, Los Angeles Dentist & San Diego Dentist at

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 3 February 2004